Edition:
United Kingdom

Interpace Diagnostics Group Inc (IDXG.OQ)

IDXG.OQ on NASDAQ Stock Exchange Capital Market

1.06USD
5:15pm BST
Change (% chg)

$0.01 (+0.95%)
Prev Close
$1.05
Open
$1.04
Day's High
$1.06
Day's Low
$1.04
Volume
6,842
Avg. Vol
41,288
52-wk High
$1.80
52-wk Low
$0.77

Latest Key Developments (Source: Significant Developments)

Interpace Diagnostics Group Q1 Revenue Rises 39 Percent
Tuesday, 15 May 2018 

May 15 (Reuters) - Interpace Diagnostics Group Inc ::INTERPACE DIAGNOSTICS GROUP REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS, BUSINESS PROGRESS AND RECENT ACCOMPLISHMENTS.Q1 REVENUE ROSE 39 PERCENT TO $4.8 MILLION.QTRLY LOSS PER SHARE $0.11.  Full Article

Interpace Diagnostics says ‍New York State Department Of Health approved its TERT service offering​
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Interpace Diagnostics Group Inc -:Interpace Diagnostics Group Inc- ‍New York State Department Of Health has reviewed and approved for marketing co's TERT service offering​.  Full Article

Interpace Diagnostics says Q3 sales up 27 pct
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Interpace Diagnostics Group Inc ::Interpace diagnostics group reports third quarter 2017 financial results, business progress and recent accomplishments.Q3 sales rose 27 percent to $4.2 million.Interpace diagnostics group inc qtrly ‍net loss per diluted share of common stock $0.15​.  Full Article

Interpace Diagnostics announces national contract with Aetna
Wednesday, 28 Jun 2017 

June 28 (Reuters) - Interpace Diagnostics Group Inc :Interpace Diagnostics announces national contract with Aetna.Interpace Diagnostics Group -Signed new national contract with Aetna for its THYGENX and Thyramir molecular tests for indeterminate thyroid nodules​.  Full Article

Interpace Diagnostics files for offering of up to $13.8 mln
Monday, 22 May 2017 

May 22 (Reuters) - Interpace Diagnostics Group Inc ::Files for offering of up to $13.8 million .Interpace Diagnostics Group - offering for shares of co's common stock and pre-funded warrants to purchase shares of its common stock.  Full Article

Interpace Diagnostics Group launches multi-site study to provide further evidence of clinical utility of ThyGenx/ThyramiR tests
Tuesday, 13 Dec 2016 

Interpace Diagnostics Group Inc :Interpace Diagnostics Group - has launched multi-site study to provide further evidence of clinical utility of thygenx/thyramir tests.  Full Article

Interpace Diagnostics launches new services for indeterminate thyroid nodules
Thursday, 13 Oct 2016 

Interpace Diagnostics Group Inc : Interpace Diagnostics launches new services for indeterminate thyroid nodules .Interpace Diagnostics Group Inc - expects new service offerings will generate an estimated 400 new specimens in first 45 days following initial launch.  Full Article

Interpace Diagnostics says Nat Krishnamurti to resign as CFO
Friday, 2 Sep 2016 

Interpace Diagnostics Group Inc : On August 29, 2016, Nat Krishnamurti tendered his resignation as CFO, secretary and treasurer of co . On August 29, 2016, company engaged James early as a consultant to serve as interim chief financial officer . Intends to commence a search for a new chief financial officer - SEC filing Source: (http://bit.ly/2bZNBZM) Further company coverage: [IDXG.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

BRIEF-Interpace Diagnostics Enters Agreement With Integrated Health Systems

* INTERPACE DIAGNOSTICS ENTERS AGREEMENT WITH ONE OF THE LARGEST, INTEGRATED HEALTH SYSTEMS IN THE US